BRIEF published on 07/30/2026 at 21:54, 12 days 21 hours ago Ikonisys SA Reports Increased Revenues and Developments in 2025 Revenue Growth Ikonisys SA Oncology Diagnostics ALIKO SCIENTIFIC Financial Results 2025
BRIEF published on 07/30/2026 at 21:54, 12 days 21 hours ago Ikonisys SA annonce des résultats annuels 2025 prometteurs Résultats Financiers Croissance Ikonisys Diagnostic Oncologique ALIKO SCIENTIFIC
BRIEF published on 07/30/2026 at 21:54, 12 days 21 hours ago Ikonisys SA announces promising annual results for 2025 Financial Results Growth Ikonisys ALIKO SCIENTIFIC Oncological Diagnosis
BRIEF published on 07/30/2026 at 21:54, 12 days 21 hours ago Ikonisys SA annonce une augmentation de son chiffre d'affaires et des développements en 2025 Ikonisys SA Croissance Des Revenus Résultats Financiers 2025 Diagnostic En Oncologie Aliko Scientifique
PRESS RELEASE published on 07/30/2026 at 21:49, 12 days 21 hours ago Informations privilégiées / Communiqué sur comptes, résultats Ikonisys SA publie ses résultats financiers annuels 2025. Amélioration de 32,9% de l'EBITDA à -1,14 M€. Développement de la plateforme oncologique avec brevet ACTA, Urine24 et accord Menarini Diagnostics Résultats Financiers EBITDA Ikonisys SA Développements Plateforme Oncologique
PRESS RELEASE published on 07/30/2026 at 21:49, 12 days 21 hours ago Inside Information / News release on accounts, results Aliko Scientific (Ikonisys SA) reports 52.6% increase in total revenue to €1.64 million and 32.9% improvement in EBITDA for 2025. Developments include US patent for ACTA, launch of Urine24, and agreement with Menarini Diagnostics Financial Results Revenue Increase EBITDA Improvement Oncology Diagnostics ALIKO SCIENTIFIC
BRIEF published on 07/23/2026 at 07:35, 20 days 11 hours ago Hospitex International Initiates Urine24 Feasibility Study in Uzbekistan Feasibility Study Cancer Diagnostics Hospitex International Urine24 Uzbek Oncology Institute
BRIEF published on 07/23/2026 at 07:35, 20 days 11 hours ago Hospitex International initiates a feasibility study in Uzbekistan for Urine24 Feasibility Study Hospitex International Uzbekistan Urine24 Oncological Diagnoses
BRIEF published on 07/23/2026 at 07:35, 20 days 11 hours ago Hospitex International lance une étude de faisabilité sur Urine24 en Ouzbékistan Étude De Faisabilité Hospitex International Diagnostic Du Cancer Urine24 Institut D'oncologie Ouzbek
BRIEF published on 07/23/2026 at 07:35, 20 days 11 hours ago Hospitex International initie une étude de faisabilité en Ouzbékistan pour Urine24 Étude De Faisabilité Hospitex International Ouzbékistan Diagnostics Oncologiques Urine24
Published on 08/12/2026 at 15:42, 3 hours 14 minutes ago Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 3 hours 14 minutes ago Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 3 hours 56 minutes ago Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 4 hours 11 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 18:17, 39 minutes ago EQS-Adhoc: Gateway Real Estate AG resolves segment change from the regulated market (Prime Standard) to the Scale segment of the open market (Freiverkehr) on the Frankfurt Stock Exchange
Published on 08/12/2026 at 18:15, 41 minutes ago Shelly Group Delivers Strong Revenue and Earnings Growth in the First Six Months of 2026
Published on 08/12/2026 at 18:00, 56 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.26
Published on 08/11/2026 at 17:45, 1 day 1 hour ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 1 hour ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
